Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Invested Capital (2019 - 2025)

Historic Invested Capital for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to -$1.7 million.

  • Biodesix's Invested Capital fell 10618.16% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year decrease of 10618.16%. This contributed to the annual value of $20.9 million for FY2024, which is 2103.49% down from last year.
  • Latest data reveals that Biodesix reported Invested Capital of -$1.7 million as of Q3 2025, which was down 10618.16% from $1.1 million recorded in Q2 2025.
  • Biodesix's 5-year Invested Capital high stood at $42.1 million for Q2 2024, and its period low was -$1.7 million during Q3 2025.
  • Over the past 5 years, Biodesix's median Invested Capital value was $20.9 million (recorded in 2024), while the average stood at $21.0 million.
  • Per our database at Business Quant, Biodesix's Invested Capital surged by 45626.32% in 2024 and then tumbled by 10618.16% in 2025.
  • Quarter analysis of 5 years shows Biodesix's Invested Capital stood at $37.5 million in 2021, then fell by 17.45% to $30.9 million in 2022, then fell by 14.57% to $26.4 million in 2023, then fell by 21.03% to $20.9 million in 2024, then plummeted by 108.25% to -$1.7 million in 2025.
  • Its Invested Capital was -$1.7 million in Q3 2025, compared to $1.1 million in Q2 2025 and $11.1 million in Q1 2025.